Authored By: Sarah
11 Sep 2023

Biologic Therapeutics Market Growth Analysis | Trends, Drivers and Vendor Forecasts for 2021-2025

Technavio has been monitoring the biologic therapeutics market and it is expected to grow by $ 226.61 bn, accelerating at a CAGR of almost 11.00% during the forecast period. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking


Biologic Therapeutics Market: Receive Free Sample Report


Biologic Therapeutics Market: Key Trends to impact market growth

The introduction of biosimilars is one of the key biologic therapeutics market market trends. This research report provides a detailed impact analysis of all the trends that are likely to influence the growth of the market in focus.

Biologic Therapeutics Market: Top Drivers to Boost Demand

Strong R&D pipeline is one of the primary factors driving the growth of the biologic therapeutics market. The report provides a detailed study of all the factors that are likely to boost the market. This analysis will enable clients to leverage growth opportunities to their advantage and set their business

Biologic Therapeutics Market Growth Analysis | Trends, Drivers and Vendor Forecasts for 2021-2025

Vendor Analysis: AbbVie Inc., AstraZeneca Plc and Bristol-Myers Squibb Co. are key growth contributors

The market is concentrated. The research report provides insights into the top market player and their product portfolio along with a pipeline analysis of upcoming developments and growth opportunities. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. AbbVie Inc., AstraZeneca Plc, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., and Sanofi SA are some of the major market participants.

For more insights on this market: Download a Free Sample Report

Biologic Therapeutics Market: Key Highlights of the Report for 2021-2025

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive biologic therapeutics market growth during the next five years
  • Precise estimation of the biologic therapeutics market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the biologic therapeutics market industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of biologic therapeutics market vendors

The report provides insights into the following FAQs:

  1. What is the market CAGR?
    The market is accelerate at a CAGR of almost 11.00%.

     
  2. What is the incremental growth of the market?
    The market is expected to grow by $ 226.61 bn through 2021-2025.

     
  3. What is a key factor driving this market?
    Strong R&D pipeline will drive market growth over the forecast period.                                                                                                                                              
  4. What are the key regions covered in this market research report?
    North America, Europe, Asia, and ROW are the key regions featured in this research report.

     
  5. Which is the leading geographic region for this market:
    57% growth will originate from North America

     
  6. Who are the leading market vendors?
    The leading vendors in this market are AbbVie Inc., AstraZeneca Plc, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., and Sanofi SA

     
  7. What are the market segments covered in this report?
    The market is segmented by Product (Antibody therapeutics, Vaccines, Cell therapy, Gene therapy, and Other therapies) and Geography (North America, Europe, Asia, and ROW)
Read News Read Less
Interested in this report?
Get your sample now!
Technavio
Document